Heart side effects from immunotherapy in cancer patients
Part of Brain & nervous system, Cancer, Heart & circulation clinical trials.
This trial looks at whether immunotherapy drugs (checkpoint inhibitors) cause heart problems in people with certain cancers. It will help doctors understand who is at risk and how to monitor for side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have esophageal, stomach, colorectal, lung, melanoma, or kidney cancer (any stage)
- You are about to start a new treatment like immunotherapy or chemotherapy
- You are 50 years or older
- You have not had immunotherapy in the last 12 months
- You do not have a serious active infection or a history of atrial fibrillation
- You do not take immune-suppressing drugs and have no known allergy to CT contrast dye
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study watches heart health in people starting immunotherapy (a cancer treatment that boosts the immune system) by checking blood samples for heart-related markers. It aims to find early signs of heart problems so they can be managed sooner.
This study looks at reports from large health databases to find out if certain cancer drugs (checkpoint inhibitors) cause heart problems. It aims to understand which patients have a higher risk, which may help doctors watch for heart issues in the future.
This trial looks at a faster heart and blood-vessel assessment for people who are taking immune cancer drugs and have been referred because they might be having a heart-related side effect. It may help by speeding up evaluation and treatment decisions when symptoms raise concern.
This study tests a new tool that helps doctors figure out your risk for heart problems after cancer treatment. If you join, you'll get a heart risk check and possibly see a heart specialist. This could help prevent heart issues later.
This study looks at whether doctors can predict heart problems caused by certain cancer treatments. It gathers information from patients before they start treatment to build better risk-checking tools.
This study looks at how targeted cancer treatments affect the heart. If you are an adult with any type of cancer and are getting or will get chemotherapy (including targeted drugs), joining this study helps doctors understand heart risks better.
Hear when a new Cardiovascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.